Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

[Early pathohistological changes in dysfunction of arteriovenous fistula for hemodialysis].

Stolić R, Mitrović S, Stolić D, Mitić N.

Vojnosanit Pregl. 2010 Jan;67(1):65-8. Serbian.

PMID:
20225638
2.

Advances and new frontiers in the pathophysiology of venous neointimal hyperplasia and dialysis access stenosis.

Lee T, Roy-Chaudhury P.

Adv Chronic Kidney Dis. 2009 Sep;16(5):329-38. doi: 10.1053/j.ackd.2009.06.009. Review.

3.

Aggressive venous neointimal hyperplasia in a pig model of arteriovenous graft stenosis.

Kelly BS, Heffelfinger SC, Whiting JF, Miller MA, Reaves A, Armstrong J, Narayana A, Roy-Chaudhury P.

Kidney Int. 2002 Dec;62(6):2272-80.

4.

Risk factors for vascular disease and arteriovenous fistula dysfunction in hemodialysis patients.

De Marchi S, Falleti E, Giacomello R, Stel G, Cecchin E, Sepiacci G, Bortolotti N, Zanello F, Gonano F, Bartoli E.

J Am Soc Nephrol. 1996 Aug;7(8):1169-77.

5.

Hemodynamics and complications encountered with arteriovenous fistulas and grafts as vascular access for hemodialysis: a review.

Van Tricht I, De Wachter D, Tordoir J, Verdonck P.

Ann Biomed Eng. 2005 Sep;33(9):1142-57. Review.

PMID:
16175669
6.

Neointimal hyperplasia in early arteriovenous fistula failure.

Roy-Chaudhury P, Arend L, Zhang J, Krishnamoorthy M, Wang Y, Banerjee R, Samaha A, Munda R.

Am J Kidney Dis. 2007 Nov;50(5):782-90.

PMID:
17954291
7.

Characterization of neointima lesions associated with arteriovenous fistulas in a mouse model.

Castier Y, Lehoux S, Hu Y, Foteinos G, Tedgui A, Xu Q.

Kidney Int. 2006 Jul;70(2):315-20. Epub 2006 Jun 7. Erratum in: Kidney Int. 2006 Sep;70(6):1190. Fonteinos, G [corrected to Foteinos, G].

8.

Restoration of autologous arteriovenous fistula by vascular stripping in a hemodialysis patient with venous neointimal hyperplasia.

Lu FP, Lu ZX, Liu X, Liu LP.

J Vasc Access. 2012 Oct-Dec;13(4):524-6. doi: 10.5301/jva.5000090.

PMID:
22865536
9.

Severe venous neointimal hyperplasia prior to dialysis access surgery.

Lee T, Chauhan V, Krishnamoorthy M, Wang Y, Arend L, Mistry MJ, El-Khatib M, Banerjee R, Munda R, Roy-Chaudhury P.

Nephrol Dial Transplant. 2011 Jul;26(7):2264-70. doi: 10.1093/ndt/gfq733. Epub 2011 Jan 10.

10.

Apoptosis and overexpression of bax protein and bax mRNA in smooth muscle cells within intimal hyperplasia of human radial arteries : analysis with arteriovenous fistulas used for hemodialysis.

Hayakawa Y, Takemura G, Misao J, Kanoh M, Ohno M, Ohashi H, Takatsu H, Ito H, Fukuda K, Fujiwara T, Minatoguchi S, Fujiwara H.

Arterioscler Thromb Vasc Biol. 1999 Sep;19(9):2066-77.

11.

Some old drugs improve late primary patency rate of native arteriovenous fistulas in hemodialysis patients.

Righetti M, Ferrario G, Serbelloni P, Milani S, Tommasi A.

Ann Vasc Surg. 2009 Jul-Aug;23(4):491-7. doi: 10.1016/j.avsg.2008.08.033. Epub 2008 Oct 29.

PMID:
18973987
12.

Preoperative venous intimal hyperplasia, postoperative arteriovenous fistula stenosis, and clinical fistula outcomes.

Allon M, Robbin ML, Young CJ, Deierhoi MH, Goodman J, Hanaway M, Lockhart ME, Litovsky S.

Clin J Am Soc Nephrol. 2013 Oct;8(10):1750-5. doi: 10.2215/CJN.02740313. Epub 2013 Jun 27.

13.

Preexisting intimal hyperplasia of radial artery is associated with early failure of radiocephalic arteriovenous fistula in hemodialysis patients.

Kim YO, Song HC, Yoon SA, Yang CW, Kim NI, Choi YJ, Lee EJ, Kim WY, Chang YS, Bang BK.

Am J Kidney Dis. 2003 Feb;41(2):422-8.

PMID:
12552505
14.

Long-term effects of erythropoietin therapy on fistula stenosis and plasma concentrations of PDGF and MCP-1 in hemodialysis patients.

De Marchi S, Cecchin E, Falleti E, Giacomello R, Stel G, Sepiacci G, Bortolotti N, Zanello F, Gonano F, Bartoli E.

J Am Soc Nephrol. 1997 Jul;8(7):1147-56.

15.

Novel paradigms for dialysis vascular access: downstream vascular biology--is there a final common pathway?

Lee T.

Clin J Am Soc Nephrol. 2013 Dec;8(12):2194-201. doi: 10.2215/CJN.03490413. Epub 2013 Aug 29. Review.

16.

Inhibitory effect of brachytherapy on intimal hyperplasia in arteriovenous fistula.

Sun S, Beitler JJ, Ohki T, Calderon TM, Schechner R, Yaparpalvi R, Berman JW, Tellis VA, Greenstein SM.

J Surg Res. 2003 Dec;115(2):200-8.

PMID:
14697284
17.

Adenovirus-mediated expression of beta-adrenergic receptor kinase C-terminus reduces intimal hyperplasia and luminal stenosis of arteriovenous polytetrafluoroethylene grafts in pigs.

Luo Z, Akita GY, Date T, Treleaven C, Vincent KA, Woodcock D, Cheng SH, Gregory RJ, Jiang C.

Circulation. 2005 Apr 5;111(13):1679-84. Epub 2005 Mar 21.

18.

Novel paradigms for dialysis vascular access: upstream hemodynamics and vascular remodeling in dialysis access stenosis.

Remuzzi A, Ene-Iordache B.

Clin J Am Soc Nephrol. 2013 Dec;8(12):2186-93. doi: 10.2215/CJN.03450413. Epub 2013 Aug 29. Review.

19.

The role of Iex-1 in the pathogenesis of venous neointimal hyperplasia associated with hemodialysis arteriovenous fistula.

Brahmbhatt A, NievesTorres E, Yang B, Edwards WD, Roy Chaudhury P, Lee MK, Kong H, Mukhopadhyay D, Kumar R, Misra S.

PLoS One. 2014 Jul 18;9(7):e102542. doi: 10.1371/journal.pone.0102542. eCollection 2014.

20.

Hemodialysis vascular access dysfunction: molecular mechanisms and treatment.

Mima A.

Ther Apher Dial. 2012 Aug;16(4):321-7. doi: 10.1111/j.1744-9987.2012.01066.x. Epub 2012 Apr 2. Review.

PMID:
22817119

Supplemental Content

Support Center